| |
While other excipients may be options for use in drug reformulations and delivery mechanisms, human serum albumin (HSA), sourced from human-derived plasma, may be preferable to artificial mediums for some uses due to its presence as a natural protein in the human body.
Human Serum Albumin is ideal for use in multiple areas of therapeutic development and production as an excipient. Some of its primary uses include:
- Stabilizer-Pharmaceutical/Biotech Products
Albumin has been widely accepted as a stabilizer source for pharmaceutical and biotech products.
- Cell Culture Medium
Albumin is widely used and accepted in cell culture processes.
- Drug Delivery Vehicle
Albumin has been widely accepted as a drug delivery vehicle. Albumin has significant binding capacity to marry with other proteins.
- Cryopreservation
Albumin has been used in the preservation of material to maintain stability over time.
- Future Uses
In addition to these more common uses, Albumin holds potential for use in the development of recombinant products, cancer vaccines, and gene therapy, and in other new medical frontiers.
Albumin products offered by CSL Behring have gained license approval from key regulatory agencies, and can meet United States Pharmacopeia and/or European Pharmacopeia specifications.
In the development, redevelopment, and manufacture of therapeutics, clearing the necessary regulatory hurdles can be a great challenge, in terms of both time and financial investment. CSL Behring has the resources to assist with your development and licensing needs-whether a new formulation, an emerging therapeutic area, or simply a switch from your current HSA brand.
No area is more important to CSL Behring than the safety and quality of its products. CSL Behring employs a highly qualified, expert team of virologists to ensure the most advanced and appropriate safety processes are used.
For further information about using CSL Behring's albumin products as an excipient, please
contact us.
For further information about CSL Behring including albumin for therapeutic use, please visit
CSL Behring.
|
|
|
